Primers on molecular pathways - The NFAT transcription pathway in pancreatic cancer

Pancreatology

Volumn 10, Issue 4, 2010, Pages 416-422

  König, Alexander ^a,b   Fernandez Zapico, Martin E ^b   Ellenrieder, Volker ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b MAYO CLINIC   (United States)

Author keywords

Nuclear factor of activated T cells; Oncogene; Pancreatic cancer

Indexed keywords

CYCLOSPORIN A; TACROLIMUS; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFATC1; TRANSCRIPTION FACTOR NFATC2; UNCLASSIFIED DRUG;

ANGIOGENESIS; CANCER GROWTH; CELL MIGRATION; CELL SURVIVAL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; MALIGNANT TRANSFORMATION; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 77955593367     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000315035     Document Type: Article

References (40)

1. Graef IA, Chen F, Crabtree GR: NFAT signaling in vertebrate development. Curr Opin Genet Dev 2001; 11:505-512.
2. Crabtree GR, Olson EN: NFAT signaling: choreographing the social lives of cells. Cell 2002; 109(suppl):S67-S79.
3. Schulz RA, Yutzey KE: Calcineurin signaling and NFAT activation in cardiovascular and skeletal muscle development. Dev Biol 2004; 266: 1-16 .
4. Macian F: NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol 2005; 5:472-484.
5. Sitara D, Aliprantis AO: Transcriptional regulation of bone and joint remodeling by NFAT. Immunol Rev 2010; 233: 286-300.
6. Jauliac S, López-Rodriguez C, Shaw LM, Brown LF, Rao A, Toker A: The role of NFAT transcription factors in integrin-mediated carcinoma invasion. Nat Cell Biol 2002; 4: 540-544.
7. Mancini M, Toker A: NFAT proteins: emerging roles in cancer progression. Nat Rev Cancer 2009; 9: 810-820 .
8. 2+ /calcineurin signaling pathway. EMBO J 2006; 25:3714-3724.
9. Graef IA, Chen F, Crabtree GR: NFAT signaling in vertebrate development. Curr Opin Genet Dev 2001; 11:505-512.
10. Beals CR, Clipstone NA, Ho SN, Crabtree GR: Nuclear localization of NF-ATc by a cal-cineurin-dependent, cyclosporin-sensitive intramolecular interaction. Genes Dev 1997; 11: 824-834.
11. 2+ /calcineurin/NFAT signaling in cancerogenesis. Cell Cycle 2007; 6:16-19.
12. Lin X, Sikkink RA, Rusnak F, Barber DL: Inhibition of calcineurin phosphatase activity by a calcineurin B homologous protein. J Biol Chem 1999; 274:36125-36131.
13. Lai MM, Burnett PE, Wolosker H, Blackshaw S, Snyder SH: Cain, a novel physiologic protein inhibitor of calcineurin. J Biol Chem 1998; 273: 18325-18331.
14. Sun L, Youn HD, Loh C, Stolow M, He W, Liu JO: Cabin 1, a negative regulator for calci-neurin signaling in T lymphocytes. Immunity 1998; 8:703-711.
15. Klauck TM, Faux MC, Labudda K, Lange-berg LK, Jaken S, Scott JD: Coordination of three signaling enzymes by AKAP79, a mammalian scaffold protein. Science 1996; 271:1589-1592.
16. Shaw KT, Ho AM, Raghavan A, Kim J, Jain J, Park J, Sharma S, Rao A, Hogan PG: Immu-nosuppressive drugs prevent a rapid dephos-phorylation of transcription factor NFAT1 in stimulated immune cells. Proc Natl Acad Sci USA 1995; 92:11205-11209.
17. Neal JW, Clipstone NA: Glycogen synthase kinase-3 inhibits the DNA binding activity of NFATc. J Biol Chem 2001; 276:3666-3673.
18. Aramburu J, Garcia-Cózar F, Raghavan A, Okamura H, Rao A, Hogan PG: Selective inhibition of NFAT activation by a peptide spanning the calcineurin targeting site of NFAT. Mol Cell 1998; 1: 627-637.
19. Aramburu J, Yaffe MB, López-Rodríguez C, Cantley LC, Hogan PG, Rao A: Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science 1999; 285:2129-2133.
20. Shibasaki F, Price ER, Milan D, McKeon F: Role of kinases and the phosphatase calci-neurin in the nuclear shuttling of transcription factor NF-AT4. Nature 1996; 382: 370-373.
21. Choo MK, Yeo H, Zayzafoon M: NFATc1 mediates HDAC-dependent transcriptional repression of osteocalcin expression during osteoblast differentiation. Bone 2009; 45: 579-589.
22. Koenig A, Linhart T, Schlengemann K, Reutlinger K, Wegele J, Adler G, Singh G, Hofmann L, Kunsch S, Büch T, Schäfer E, Gress TM, Fernandez-Zapico ME, Ellenrie-der V: NFAT-induced histone acetylation relay switch promotes c-Myc-dependent growth in pancreatic cancer cells. Gastroen-terolog y 2010; 138: 1189-1199.
23. Darnell JE Jr: STATs and gene regulation. Science 1997; 277:1630-1635.
24. Yu H, Jove R: The STATs of cancer-new molecular targets come of age. Nat Rev Cancer 2004; 4: 97-105.
25. Lagunas L, Clipstone NA: Deregulated NFATc1 activity transforms murine fibro-blasts via an autocrine growth factor-mediated Stat3-dependent pathway. J Cell Bio-chem 2009; 108 : 237-248.
26. Crabtree GR: Contingent genetic regulatory events in T lymphocyte activation. Science 1989; 243: 355-361.
27. Woodrow M, Clipstone NA, Cantrell D: p21ras and calcineurin synergize to regulate the nuclear factor of activated T cells. J Exp Med 1993; 178:1517-1522.
28. Nayak A, Glöckner-Pagel J, Vaeth M, Schumann JE , Buttmann M, Bopp T, Schmitt E, Serfling E, Berberich-Siebelt F: Su-moylation of the transcription factor NFATc1 leads to its subnuclear relocalization and in-terleukin-2 repression by histone deacety-lase. J Biol Chem 2009; 284:10935-10946.
29. Olabisi OA, Soto-Nieves N, Nieves E, Yang TT, Yang X, Yu RY, Suk HY, Macian F, Chow CW: Regulation of transcription factor NFAT by ADP-ribosylation. Mol Cell Biol 2008; 28:2860-2871.
30. Gwack Y, Sharma S, Nardone J, Tanasa B, Iuga A, Srikanth S, Okamura H, Bolton D, Feske S, Hogan PG, Rao A: A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT. Nature 2006;441: 646-650.
31. Kuhn C, Frank D, Will R, Jaschinski C, Frauen R, Katus HA, Frey N: DYRK1A is a novel negative regulator of cardiomyocyte hypertrophy. J Biol Chem 2009; 284:17320-17327.
32. Beals CR, Sheridan CM, Turck CW, Gardner P, Crabtree GR: Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 1997; 275: 1930-1934 .
33. Porter CM, Havens MA, Clipstone NA: Identification of amino acid residues and protein kinases involved in the regulation of NFATc subcellular localization. J Biol Chem 2000; 275: 35 43-3551.
34. Zhu J, Shibasaki F, Price R, Guillemot JC, Yano T, Dötsch V, Wagner G, Ferrara P, McKeon F: Intramolecular masking of nuclear import signal on NF-AT4 by casein ki-nase I and MEKK1. Cel l 1998; 93: 851-8 61.
35. Neal JW, Clipstone NA: A constitutively active NFATc1 mutant induces a transformed phenotype in 3T3-L1 fibroblasts. J Biol Chem 20 03; 278: 17246-17254.
36. Robbs BK, Cruz AL, Werneck MB, Mognol GP, Viola JP: Dual roles for NFAT transcription factor genes as oncogenes and tumor suppressors. Mol Cell Biol 2008; 28: 7168-7181.
37. Caetano MS, Vieira-de-Abreu A, Teixeira LK, Werneck MB, Barcinski MA, Viola JP: NFATC2 transcription factor regulates cell cycle progression during lymphocyte activation: evidence of its involvement in the control of cyclin gene expression. FASEB J 2002; 16 : 194 0-194 2 .
38. Ellenrieder V, Hendler SF, Ruhland C, Boeck W, Adler G, Gress TM: TGF-beta-induced i nvasiveness of pa ncreatic cancer cel ls is mediated by matrix metalloproteinase-2 and the urokinase plasminogen activator system. Int J Cancer 2001; 93: 204-211.
39. Velupillai P, Sung CK, Tian Y, Dahl J, Carroll J, Bronson R, Benjamin T: Polyoma virus-induced osteosarcomas in inbred strains of mice: host determinants of metastasis. PLoS Pathog 2010; 22: e1000733.
40. Ellenrieder V, Hendler SF, Boeck W, Seuffer-lein T, Menke A, Ruhland C, Adler G, Gress TM: Transforming growth factor beta1 treatment leads to an epithelial-mesenchy-mal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation. Cancer Res 2001; 61: 4222-4228.